Fairmount Funds Management LLC
Director at Apogee Therapeutics · 22 reported transactions in 9 companies · latest trade Jul 16, 2026
Their record
Across their whole record, 4 purchases can be measured; 2 did better than the S&P 500 over the next 6 months.
Typical move +59.0%, S&P 500 +9.8% over the same days.
Their trades
Bought | Jul 16, 2026 | Jul 16, 2026 close $15.11 → Oct 29, 2026 close $14.07. S&P 500 +2.9% over the same days. | ||
Sold | Jul 1, 2026 | Jul 1, 2026 close $93.29 → Oct 29, 2026 close $96.65. S&P 500 +3.6% over the same days. | ||
Sold | Jun 23, 2026 | Jun 23, 2026 close $97.05 → Oct 29, 2026 close $98.96. S&P 500 +5.3% over the same days. |
BoughtCrescent Biopharma
$12.38M
Jul 16, 2026 close $15.11 → Oct 29, 2026 close $14.07. S&P 500 +2.9% over the same days.
$300.01M
Jul 1, 2026 close $93.29 → Oct 29, 2026 close $96.65. S&P 500 +3.6% over the same days.
$399.66M
Jun 23, 2026 close $97.05 → Oct 29, 2026 close $98.96. S&P 500 +5.3% over the same days.